US Broker Ratings

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Poised for a 29.89% Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a notable player in the healthcare sector, is capturing investor attention with its diverse portfolio of over-the-counter (OTC) health and..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 37.35% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, the..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 4.15% Upside in the Biotech Sector

In the intricate landscape of biotechnology investments, Akero Therapeutics, Inc. (NASDAQ: AKRO) stands out as a compelling player. With a market capitalization of $4.31 billion, this..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potential Amid Industry Challenges

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Wilmington, Massachusetts,..

Vaxcyte, Inc. (PCVX) Investor Outlook: Unpacking a 132% Potential Upside in the Biotech Space

For investors with an interest in the burgeoning field of biotechnology, Vaxcyte, Inc. (PCVX) presents a compelling opportunity. With a current market capitalization of $5.48 billion,..

BrightSpring Health Services (BTSG) Stock Report: Analyst Consensus and Growth Potential

BrightSpring Health Services, Inc. (BTSG) is emerging as a noteworthy player in the Healthcare sector, specifically within the Health Information Services industry. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth with a 2.13% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a prominent player in the global pharmaceutical landscape, hailing from India and making significant strides in the Healthcare..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 85% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a potential upside of 85.42%, as analysts set their sights on a promising future for this..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Evaluating Its Potential Amidst a $7.86 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a key player in the healthcare sector, has been making waves with its focus on Traditional Chinese Medicine (TCM) for..

Cytokinetics, Incorporated (CYTK): Analyst Ratings Show 31% Potential Upside for Biotechnology Innovator

Cytokinetics, Incorporated (NASDAQ: CYTK) has been making waves in the biotechnology sector with its focus on developing muscle activators and inhibitors for treating debilitating diseases. With..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 36% Potential Upside with Solid Analyst Ratings

Investors seeking opportunities within the healthcare sector’s medical instruments and supplies industry may find AptarGroup, Inc. (NYSE: ATR) an intriguing prospect. With a market capitalization of..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Diagnostic Frontier with 30.9% Revenue Growth

Guardant Health, Inc. (NASDAQ: GH), a key player in the diagnostics and research industry, has been making waves with its innovative contributions to precision oncology. With..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Path with -35.85% Potential Downside

Oscar Health, Inc. (NYSE: OSCR) continues to capture the attention of investors navigating the volatile healthcare sector. As a healthcare technology company based in New York,..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 28.81% Potential Upside for Savvy Investors

Investors keen on tapping into the healthcare sector’s promising growth may find Grifols, S.A. (GRFS) an intriguing prospect. With its roots firmly planted in the drug..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Robust Growth Trajectory with 8.52% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its innovative approach to organ transplant therapy. The company’s unique Organ Care System..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a Potential 86.50% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) has captured the attention of investors with its promising growth trajectory within the biotechnology sector. Headquartered in Redwood City, California, Corcept..

Glaukos Corporation (GKOS) Stock Analysis: Navigating a 60% Potential Upside in the Medical Devices Sector

In the rapidly evolving medical devices sector, Glaukos Corporation (NYSE: GKOS) stands out as a formidable player specializing in ophthalmic pharmaceuticals and medical technologies. With a..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 19% Potential Upside in the Medical Devices Sector

Investors looking for opportunities in the healthcare sector may want to keep an eye on Bruker Corporation (NASDAQ: BRKR). With a market capitalization of $5.92 billion,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Strong Buy Ratings Signal Robust Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is drawing significant investor attention in the biotechnology sector, primarily due to its innovative focus on rare neuroendocrine diseases. With a..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Exploring an 8.35% Dividend Yield Amidst Challenging Metrics

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a formidable player in the healthcare and pharmaceutical retail sector, with a sprawling global presence that spans the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds